Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.1422
-0.0090 (-5.95%)
At close: Jun 5, 2026, 4:00 PM EDT
0.1400
-0.0022 (-1.55%)
After-hours: Jun 5, 2026, 7:58 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $6.38 million as of June 5, 2026. Its market cap has decreased by -96.01% in one year.
Market Cap
6.38M
Enterprise Value
5.92M
1-Year Change
-96.01%
Ranking
Category
Stock Price
$0.14
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $6.38M, a decrease of -98.16%. That is a compound annual growth rate of -54.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 6.38M | -61.35% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 7.68M |
| Acurx Pharmaceuticals | 7.57M |
| Genprex | 7.36M |
| Processa Pharmaceuticals | 7.32M |
| Enveric Biosciences | 7.22M |
| Can-Fite BioPharma | 6.70M |
| Silo Pharma | 6.63M |
| SciSparc | 6.62M |